DE69904206T2 - Verwendung von cetirizin zur vorbeugung von asthma eintritt - Google Patents

Verwendung von cetirizin zur vorbeugung von asthma eintritt

Info

Publication number
DE69904206T2
DE69904206T2 DE69904206T DE69904206T DE69904206T2 DE 69904206 T2 DE69904206 T2 DE 69904206T2 DE 69904206 T DE69904206 T DE 69904206T DE 69904206 T DE69904206 T DE 69904206T DE 69904206 T2 DE69904206 T2 DE 69904206T2
Authority
DE
Germany
Prior art keywords
cetirizine
entry
prevent asthma
asthma
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69904206T
Other languages
English (en)
Other versions
DE69904206D1 (de
Inventor
Luc Uylenbroeck
Longueville Marc De
Anne Wilmes
Clercq Johan De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Farchim SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26792214&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69904206(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by UCB SA filed Critical UCB SA
Publication of DE69904206D1 publication Critical patent/DE69904206D1/de
Application granted granted Critical
Publication of DE69904206T2 publication Critical patent/DE69904206T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69904206T 1998-08-18 1999-08-14 Verwendung von cetirizin zur vorbeugung von asthma eintritt Expired - Lifetime DE69904206T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9692998P 1998-08-18 1998-08-18
US9745598P 1998-08-21 1998-08-21
PCT/EP1999/005969 WO2000010544A2 (en) 1998-08-18 1999-08-14 A method for preventing the onset of asthma

Publications (2)

Publication Number Publication Date
DE69904206D1 DE69904206D1 (de) 2003-01-09
DE69904206T2 true DE69904206T2 (de) 2003-07-17

Family

ID=26792214

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69904206T Expired - Lifetime DE69904206T2 (de) 1998-08-18 1999-08-14 Verwendung von cetirizin zur vorbeugung von asthma eintritt

Country Status (16)

Country Link
EP (1) EP1109557B1 (de)
JP (1) JP3878416B2 (de)
AR (1) AR020167A1 (de)
AT (1) ATE228366T1 (de)
AU (1) AU749169B2 (de)
CA (1) CA2340920C (de)
DE (1) DE69904206T2 (de)
ES (1) ES2188232T3 (de)
HN (1) HN1999000140A (de)
MA (1) MA26676A1 (de)
MY (1) MY124089A (de)
PA (1) PA8480401A1 (de)
SA (1) SA99200492B1 (de)
TN (1) TNSN99158A1 (de)
TW (1) TW581675B (de)
WO (1) WO2000010544A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
WO2005077371A1 (en) * 2004-02-12 2005-08-25 Ucb Farchim Sa Use of levocetirizine for the preparation of a drug
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof

Also Published As

Publication number Publication date
TW581675B (en) 2004-04-01
DE69904206D1 (de) 2003-01-09
CA2340920A1 (en) 2000-03-02
AU5734699A (en) 2000-03-14
JP2002523362A (ja) 2002-07-30
WO2000010544A3 (en) 2000-05-18
HN1999000140A (es) 2001-07-31
ES2188232T3 (es) 2003-06-16
ATE228366T1 (de) 2002-12-15
TNSN99158A1 (ar) 2005-11-10
MY124089A (en) 2006-06-30
PA8480401A1 (es) 2000-09-29
EP1109557B1 (de) 2002-11-27
AU749169B2 (en) 2002-06-20
EP1109557A2 (de) 2001-06-27
MA26676A1 (fr) 2004-12-20
SA99200492B1 (ar) 2006-06-04
AR020167A1 (es) 2002-04-10
WO2000010544A2 (en) 2000-03-02
CA2340920C (en) 2007-10-16
JP3878416B2 (ja) 2007-02-07

Similar Documents

Publication Publication Date Title
DE69903655D1 (de) Verwendung von menthyl-2-pyrrolidon-5-carboxylat zur insektenabwehr
DE60037213D1 (de) Verwendung von Reinigungsgas
DE69833134D1 (de) Verwendung aliphatischer amine zur verminderung von oxalat
DE59810802D1 (de) Verwendung von anorganisch-organischen hybridprepolymeren
DE59905858D1 (de) Verwendung von pit-emulsionen
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69927128T2 (de) Verwendung von topisch applizierbaren Gerinnungsmaterial
ID27092A (id) Pembuatan ftalat anhidrida
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
DE59807740D1 (de) Verwendung von aerogelen zur körper- und/oder trittschalldämmung
DE50212455D1 (de) Verwendung von Dimerdiolen
DE59902868D1 (de) Verwendung von ectoin oder ectoin-derivaten in formulierungen
DE60021903D1 (de) Verwendung von zusammensetzungen zur textilpflege
DE60211632D1 (de) Verwendung von Cyclotetrasaccharide zur Erhöhung der "Aktiven-Sauerstoff-Eliminierenden-Aktivität"
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
DE9421095U1 (de) Integriertes Analysengerät zur Bestimmung des Gasverbrauchs von Materie
DE69928437D1 (de) Verwendung von paraoxanase-1 (pon-1) zur reduzierung der atheroma-bildung und der hypercholesterolemie
DE69922558D1 (de) Herstellung von Aluminiumoxid
DE69900514D1 (de) Herstellung von Polyalkylsilsesquioxan-Partikeln
DE69904206D1 (de) Verwendung von cetirizin zur vorbeugung von asthma eintritt
ATE243197T1 (de) Kristallformen von osanetant
DE59811806D1 (de) Verwendung von ausgewählten phytostenolestern zur herstellung von hypocholesterinämischen mitteln
ATE303153T1 (de) Ibandroinsäure zur förderung der osseointegration der endoprothesen
DE69723702D1 (de) Verwendung von hyaluronsäure zur zellmobilisierung
DE69904567D1 (de) Lipidmischung sowie ihre verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: UCB FARCHIM S.A., BULLE, CH